ImmunoACT gets nod for leukaemia, lymphoma cancer therapy in India
HQ Team October 16, 2023: India’s Immunoactive Cell Therapy Ltd., has got a marketing authorisation from the drug regulator for a therapy to.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team October 16, 2023: India’s Immunoactive Cell Therapy Ltd., has got a marketing authorisation from the drug regulator for a therapy to.
HQ Team September 11, 2023: Moderna Inc. announced a pact with Immatics NV, a clinical-stage biopharmaceutical company, to develop cancer therapies using a.
HQ Team August 7, 2023: Anixa Biosciences, Inc., announced that its partner Cleveland Clinic has begun enrolling subjects in a treatment arm to.
HQ Team April 17, 2023: US-based Merck will buy Prometheus Biosciences for about 10.8 billion to shore up its immunology portfolio to shield itself from.
Activation of bio-therapeutic drugs by switching on LEDs embedded close to a tumour may be cancer immunotherapy's future, researchers found.
Israeli researchers have succeeded in making computers into pathological assistants at a time when healthcare companies are trying to overcome a global shortage.